All Stories

  1. Discerning excipient functionality: Lubricants vs. anti-adherents
  2. Predicting the tabletability of binary powder mixtures from that of individual components
  3. A Global Analysis of the Mechanical Properties of Organic Glasses Below Tg
  4. An integrated material-sparing method for determining dilution potential of direct compression tablet fillers
  5. Unveiling the Structure of Anhydrous Sodium Valproate with 3D Electron Diffraction and a Facile Sample Preparation Workflow
  6. Modulating Milling-Induced Amorphization Propensity of Drug Crystals by Cocrystallization
  7. Unveiling the Structure of Anhydrous Sodium Valproate with 3D Electron Diffraction and a Facile Sample Preparation Workflow
  8. Elucidating critical factors driving the tabletability flip phenomenon
  9. Decreased Crystal Plasticity by Solvation – the Case of Levofloxacin Acesulfame
  10. Preparation and solid-state characterization of two novel berberine chloride cocrystals with benzene derivatives
  11. Some properties and applications of the tabletability equation
  12. Impact of solid content on the bulk properties of lyophilized powders
  13. Simultaneously improving tabletability and solubility of diclofenac by cocrystallization with picolinamide
  14. Direct compression tablet formulation of trimetazidine through systematic screening of oxalate salts
  15. Efficient Development of High Drug Loaded Posaconazole Tablets Enabled by Amorphous Solid Dispersion
  16. Impact of route of particle engineering on dissolution performance of posaconazole
  17. Delaying the first nucleation event of amorphous solid dispersions above the polymer overlap concentration (c*): PVP and PVPVA in posaconazole
  18. Efficient determination of critical water activity and classification of hydrate-anhydrate stability relationship
  19. Miscibility of amorphous solid dispersions: A rheological and solid-state NMR spectroscopy study
  20. How elastically flexible can molecular crystals be? – a new record
  21. An evaluation of six techniques for measuring porosity of ribbons produced by roller compaction
  22. Crystal structure-mechanical property relationship in succinic acid and L- alanine probed by nanoindentation
  23. Plasticization of a stiff pharmaceutical solid for better tabletability via cocrystallization: Shape synthons as supramolecular protecting groups
  24. Advancing the Harmonization of Biopredictive Methodologies through the Product Quality Research Institute (PQRI) Consortium: Biopredictive Dissolution of Dipyridamole Tablets
  25. A systematic comparison of four pharmacopoeial methods for measuring powder flowability
  26. Surface Engineering of the Mechanical Properties of Molecular Crystals via an Atomistic Model for Computing the Facet Stress Response of Solids
  27. Understanding the roles of compaction pressure and crystal hardness on powder tabletability through bonding area – Bonding strength interplay
  28. Surface Engineering of the Mechanical Properties of Molecular Crystals via an Atomistic Model for Computing the Facet Stress Response of Solids
  29. Surface Engineering of the Mechanical Properties of Molecular Crystals via an Atomistic Model for Computing the Facet Stress Response of Solids
  30. Relative Bioavailability Assessment of Solid Forms by An Artificial Stomach and Duodenum Apparatus
  31. A strategy to optimize precompression pressure for tablet manufacturing based on in-die elastic recovery
  32. A new insight into the mechanism of the tabletability flip phenomenon
  33. Cocrystallization improves the tabletability of ligustrazine despite a reduction in plasticity
  34. Development of direct compression Acetazolamide tablet with improved bioavailability in healthy human volunteers enabled by cocrystallization with p-Aminobenzoic acid
  35. Tuning Caco-2 permeability by cocrystallization: Insights from molecular dynamics simulation
  36. Worsened punch sticking by external lubrication with magnesium stearate
  37. Effect of drug loading and relative humidity on the mechanical properties and tableting performance of Celecoxib–PVP/VA 64 amorphous solid dispersions
  38. The ubiquity of the tabletability flip phenomenon
  39. Correction: Harmonizing Biopredictive Methodologies Through the Product Quality Research Institute (PQRI) Part I: Biopredictive Dissolution of Ibuprofen and Dipyridamole Tablets
  40. Enabling direct compression tablet formulation of celecoxib by simultaneously eliminating punch sticking, improving manufacturability, and enhancing dissolution through co-processing with a mesoporous carrier
  41. Understanding the role of magnesium stearate in lowering punch sticking propensity of drugs during compression
  42. Modulating Pharmaceutical Properties of Berberine Chloride through Cocrystallization with Benzendiol Isomers
  43. Harmonizing Biopredictive Methodologies Through the Product Quality Research Institute (PQRI) Part I: Biopredictive Dissolution of Ibuprofen and Dipyridamole Tablets
  44. An approach for predicting the true density of powders based on in-die compression data
  45. A material-sparing simplified buoyancy method for determining the true density of solids
  46. Structural Origin of Anisotropic Thermal Expansion of Molecular Crystals and Implication for the Density Rule Probed with Four ROY Polymorphs
  47. Magnesium stearate surface coverage on tablets and drug crystals: Insights from SEM-EDS elemental mapping
  48. A Rheological Approach for Predicting Physical Stability of Amorphous Solid Dispersions
  49. Mechanical properties and peculiarities of molecular crystals
  50. Professor Raj Suryanarayanan: Scientist, Educator, Mentor, Family Man and Giant in Pharmaceutical Research
  51. A critical examination of three-point bending for determining Young’s modulus
  52. Crystal and Particle Engineering – An Indispensable Tool for Developing and Manufacturing Quality Pharmaceutical Products
  53. Varied Bulk Powder Properties of Micro-Sized API within Size Specifications as a Result of Particle Engineering Methods
  54. Bioavailability-Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance
  55. An extended macroindentation method for determining the hardness of poorly compressible materials
  56. A powder tabletability equation
  57. Profound effects of gastric secretion rate variations on the precipitation of erlotinib in duodenum – An in vitro investigation
  58. Nanomechanical testing in drug delivery: Theory, applications, and emerging trends
  59. Complexation with aromatic carboxylic acids expands the solid-state landscape of berberine
  60. Mechanisms of Crystal Plasticization by Lattice Water
  61. Air entrapment during tablet compression – Diagnosis, impact on tableting performance, and mitigation strategies
  62. Simultaneous improvement of physical stability, dissolution, bioavailability, and antithrombus efficacy of Aspirin and Ligustrazine through cocrystallization
  63. Effects of shear cell size on flowability of powders measured using a ring shear tester
  64. Formulation strategies for mitigating dissolution reduction of p-aminobenzoic acid by sodium lauryl sulfate through diffusion layer modulation
  65. Stress transmission coefficient is a reliable and robust parameter for quantifying powder plasticity
  66. Profoundly improved photostability of dimetronidazole by cocrystallization
  67. Efficient development of sorafenib tablets with improved oral bioavailability enabled by coprecipitated amorphous solid dispersion
  68. Mean yield pressure from the in-die Heckel analysis is a reliable plasticity parameter
  69. Exceptional Powder Tabletability of Elastically Flexible Crystals
  70. Pharmaceutical Lauryl Sulfate Salts: Prevalence, Formation Rules, and Formulation Implications
  71. An Elusive Drug–Drug Cocrystal Prepared Using a Heteroseeding Strategy
  72. Effect of Lipidic Excipients on the Particle Properties and Aerosol Performance of High Drug Load Spray Dried Particles for Inhalation
  73. Effects of compaction and storage conditions on stability of intravenous immunoglobulin – Implication on developing oral tablets of biologics
  74. Drug–Drug Cocrystallization Simultaneously Improves Pharmaceutical Properties of Genistein and Ligustrazine
  75. Improving the Solubility, Dissolution, and Bioavailability of Metronidazole via Cocrystallization with Ethyl Gallate
  76. Nanomechanical mapping and strain rate sensitivity of microcrystalline cellulose
  77. Novel Salt-Cocrystals of Berberine Hydrochloride with Aliphatic Dicarboxylic Acids: Odd–Even Alternation in Physicochemical Properties
  78. Direct compression tablet formulation of celecoxib enabled with a pharmaceutical solvate
  79. How Does the Dissimilarity of Screw Geometry Impact Twin-screw Melt Granulation?
  80. Low-dose salinomycin inhibits breast cancer metastasis by repolarizing tumor hijacked macrophages toward the M1 phenotype
  81. Modulation of the powder properties of lamotrigine by crystal forms
  82. Structural Origins of Elastic and 2D Plastic Flexibility of Molecular Crystals Investigated with Two Polymorphs of Conformationally Rigid Coumarin
  83. Sweet Sulfamethazine Acesulfamate Crystals with Improved Compaction Property
  84. Mechanically responsive crystalline materials
  85. Reversible facile single-crystal-to-single-crystal polymorphic transition accompanied by unit cell volume expansion and twinning
  86. Cocrystal engineering of pharmaceutical solids: therapeutic potential and challenges
  87. The impact of solid-state form, water content and surface area of magnesium stearate on lubrication efficiency, tabletability, and dissolution
  88. Tabletability Flip – Role of Bonding Area and Bonding Strength Interplay
  89. Structural Insights into the Distinct Solid-State Properties and Interconversion of Celecoxib N-Methyl-2-pyrrolidone Solvates
  90. Discovery, Characterization, and Pharmaceutical Applications of Two Loratadine–Oxalic Acid Cocrystals
  91. The efficient development of a sildenafil orally disintegrating tablet using a material sparing and expedited approach
  92. Development of piroxicam mini-tablets enabled by spherical cocrystallization
  93. Profound tabletability deterioration of microcrystalline cellulose by magnesium stearate
  94. Novel Quasi-Emulsion Solvent Diffusion-Based Spherical Cocrystallization Strategy for Simultaneously Improving the Manufacturability and Dissolution of Indomethacin
  95. Effect of Hydroxypropyl Cellulose Level on Twin-Screw Melt Granulation of Acetaminophen
  96. Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal– a QbD Approach
  97. A microcrystalline cellulose based drug-composite formulation strategy for developing low dose drug tablets
  98. Molecular Origin of the Distinct Tabletability of Loratadine and Desloratadine: Role of the Bonding Area – Bonding Strength Interplay
  99. Intermolecular interactions and disorder in six isostructural celecoxib solvates
  100. Mitigating Punch Sticking Propensity of Celecoxib by Cocrystallization: An Integrated Computational and Experimental Approach
  101. Conformation Directed Interaction Anisotropy Leading to Distinct Bending Behaviors of Two ROY Polymorphs
  102. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies
  103. Reduction of Punch-Sticking Propensity of Celecoxib by Spherical Crystallization via Polymer Assisted Quasi-Emulsion Solvent Diffusion
  104. Toward a Molecular Understanding of the Impact of Crystal Size and Shape on Punch Sticking
  105. Simultaneous taste-masking and oral bioavailability enhancement of Ligustrazine by forming sweet salts
  106. Extended Release of Highly Water Soluble Isoniazid Attained through Cocrystallization with Curcumin
  107. Reducing the Sublimation Tendency of Ligustrazine through Salt Formation
  108. The role of the screw profile on granular structure and mixing efficiency of a high-dose hydrophobic drug formulation during twin screw wet granulation
  109. A systematic evaluation of poloxamers as tablet lubricants
  110. Interfacial bonding in formulated bilayer tablets
  111. A material-saving and robust approach for obtaining accurate out-of-die powder compressibility
  112. Molecular Interpretation of Mechanical Behavior in Four Basic Crystal Packing of Isoniazid with Homologous Cocrystal Formers
  113. Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods
  114. Expedited Investigation of Powder Caking Aided by Rapid 3D Prototyping of Testing Devices
  115. The landscape of mechanical properties of molecular crystals
  116. Workshop Report: USP Workshop on Advancements in In Vitro Performance Testing of Drug Products
  117. Crystallographic and Energetic Insights into Reduced Dissolution and Physical Stability of a Drug–Surfactant Salt: The Case of Norfloxacin Lauryl Sulfate
  118. Molecular Interpretation of the Compaction Performance and Mechanical Properties of Caffeine Cocrystals: A Polymorphic Study
  119. Improving Powder Characteristics by Surface Modification Using Atomic Layer Deposition
  120. Correction to Fast Determination of Phase Stability of Hydrates Using Intrinsic Dissolution Rate Measurements
  121. Effect of particle size on interfacial bonding strength of bilayer tablets
  122. Structural Features of Sulfamethizole and Its Cocrystals: Beauty Within
  123. Fast Determination of Phase Stability of Hydrates Using Intrinsic Dissolution Rate Measurements
  124. Insights into the effect of compaction pressure and material properties on interfacial bonding strength of bilayer tablets
  125. Relationship between hydrate stability and accuracy of true density measured by helium pycnometry
  126. Minimum Interfacial Bonding Strength for Bilayer Tablets Determined Using a Survival Test
  127. Correction to Crystal Growth of Celecoxib from Amorphous State: Polymorphism, Growth Mechanism, and Kinetics
  128. Single-Crystal Plasticity Defies Bulk-Phase Mechanics in Isoniazid Cocrystals with Analogous Coformers
  129. Tableting performance of various mannitol and lactose grades assessed by compaction simulation and chemometrical analysis
  130. Crystal growth of celecoxib from amorphous state – polymorphism, growth mechanism, and kinetics
  131. Reduced Punch Sticking Propensity of Acesulfame by Salt Formation: Role of Crystal Mechanical Property and Surface Chemistry
  132. Twistable Pharmaceutical Crystal Exhibiting Exceptional Plasticity and Tabletability
  133. Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer
  134. Effect of screw profile and processing conditions on physical transformation and chemical degradation of gabapentin during twin-screw melt granulation
  135. Direct Compression Tablet Containing 99% Active Ingredient—A Tale of Spherical Crystallization
  136. Cocrystal Engineering of Itraconazole with Suberic Acid via Rotary Evaporation and Spray Drying
  137. Computational Techniques for Predicting Mechanical Properties of Organic Crystals: A Systematic Evaluation
  138. Profoundly Improved Plasticity and Tabletability of Griseofulvin by in Situ Solvation and Desolvation during Spherical Crystallization
  139. Spherical Cocrystallization—An Enabling Technology for the Development of High Dose Direct Compression Tablets of Poorly Soluble Drugs
  140. Effects of thermal binders on chemical stabilities and tabletability of gabapentin granules prepared by twin-screw melt granulation
  141. Effects of Water on Powder Flowability of Diverse Powders Assessed by Complimentary Techniques
  142. Exceptionally Elastic Single-Component Pharmaceutical Crystals
  143. Developing Biologics Tablets: The Effects of Compression on the Structure and Stability of Bovine Serum Albumin and Lysozyme
  144. Polymer Nanocoating of Amorphous Drugs for Improving Stability, Dissolution, Powder Flow, and Tabletability: The Case of Chitosan-Coated Indomethacin
  145. Robust bulk preparation and characterization of sulfamethazine and saccharine salt and cocrystal polymorphs
  146. A platform direct compression formulation for low dose sustained-release tablets enabled by a dual particle engineering approach
  147. Improving solid-state properties of berberine chloride through forming a salt cocrystal with citric acid
  148. Mechanism for the Reduced Dissolution of Ritonavir Tablets by Sodium Lauryl Sulfate
  149. Proportionality between powder cohesion and unconfined yield strength from shear cell testing
  150. Cubosomes with surface cross-linked chitosan exhibit sustained release and bioavailability enhancement for vinpocetine
  151. Structures and Properties of Granules Prepared By High Shear Wet Granulation
  152. A systematic evaluation of dual functionality of sodium lauryl sulfate as a tablet lubricant and wetting enhancer
  153. Mechanical Properties
  154. Cocrystallization of Curcumin with Benzenediols and Benzenetriols via Rapid Solvent Removal
  155. Preparation, Characterization, and Formulation Development of Drug–Drug Protic Ionic Liquids of Diphenhydramine with Ibuprofen and Naproxen
  156. Ribbon density and milling parameters that determine fines fraction in a dry granulation
  157. Comparative analyses of flow and compaction properties of diverse mannitol and lactose grades
  158. Anion Exchange Reaction for Preparing Acesulfame Solid Forms
  159. Relating the tableting behavior of piroxicam polytypes to their crystal structures using energy-vector models
  160. Systematic evaluation of common lubricants for optimal use in tablet formulation
  161. The relationship among tensile strength, Young's modulus, and indentation hardness of pharmaceutical compacts
  162. Crystal and Particle Engineering Strategies for Improving Powder Compression and Flow Properties to Enable Continuous Tablet Manufacturing by Direct Compression
  163. Modulating Sticking Propensity of Pharmaceuticals Through Excipient Selection in a Direct Compression Tablet Formulation
  164. A mesoporous silica based platform to enable tablet formulations of low dose drugs by direct compression
  165. Identifying Slip Planes in Organic Polymorphs by Combined Energy Framework Calculations and Topology Analysis
  166. Reduced interface spin polarization by antiferromagnetically coupled Mn segregated to the Co2MnSi /GaAs (001) interface
  167. Lack of dependence of mechanical properties of baicalein cocrystals on those of the constituent components
  168. Subsurface nucleation of supercooled acetaminophen
  169. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer
  170. Relationships among Crystal Structures, Mechanical Properties, and Tableting Performance Probed Using Four Salts of Diphenhydramine
  171. Dependence of Friability on Tablet Mechanical Properties and a Predictive Approach for Binary Mixtures
  172. Expedited development of a high dose orally disintegrating metformin tablet enabled by sweet salt formation with acesulfame
  173. The suitability of common compressibility equations for characterizing plasticity of diverse powders
  174. Tablets of multi-unit pellet system for controlled drug delivery
  175. Expedited Development of Diphenhydramine Orally Disintegrating Tablet through Integrated Crystal and Particle Engineering
  176. Ribbon thickness influences fine generation during dry granulation
  177. Dependence of Punch Sticking on Compaction Pressure—Roles of Particle Deformability and Tablet Tensile Strength
  178. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression
  179. Dapagliflozin-citric acid cocrystal showing better solid state properties than dapagliflozin
  180. Superior Plasticity and Tabletability of Theophylline Monohydrate
  181. Gaining insight into tablet capping tendency from compaction simulation
  182. Tensile and shear methods for measuring strength of bilayer tablets
  183. Powder properties and compaction parameters that influence punch sticking propensity of pharmaceuticals
  184. Lubrication with magnesium stearate increases tablet brittleness
  185. A top coating strategy with highly bonding polymers to enable direct tableting of multiple unit pellet system (MUPS)
  186. Mechanical Properties and Tableting Behavior of Amorphous Solid Dispersions
  187. Mechanism and Kinetics of Punch Sticking of Pharmaceuticals
  188. Preparation of slab-shaped lactose carrier particles for dry powder inhalers by air jet milling
  189. Self-templating accelerates precipitation of carbamazepine dihydrate during the dissolution of a soluble carbamazepine cocrystal
  190. The phenomenon of tablet flashing — Its impact on tableting data analysis and a method to eliminate it
  191. Harvesting Potential Dissolution Advantages of Soluble Cocrystals by Depressing Precipitation Using the Common Coformer Effect
  192. Process optimization of dry granulation based tableting line: Extracting physical material characteristics from granules, ribbons and tablets using near-IR (NIR) spectroscopic measurement
  193. Analytical method development for powder characterization: Visualization of the critical drug loading affecting the processability of a formulation for direct compression
  194. Solid-state characterization of optically pure (+)Dihydromyricetin extracted from Ampelopsis grossedentata leaves
  195. Enhancing Bioavailability of Dihydromyricetin through Inhibiting Precipitation of Soluble Cocrystals by a Crystallization Inhibitor
  196. A classification system for tableting behaviors of binary powder mixtures
  197. Microstructure of Tablet—Pharmaceutical Significance, Assessment, and Engineering
  198. Resveratrol cocrystals with enhanced solubility and tabletability
  199. Macroindentation hardness measurement—Modernization and applications
  200. Enabling the Tablet Product Development of 5-Fluorocytosine by Conjugate Acid Base Cocrystals
  201. Mini review: Mechanisms to the loss of tabletability by dry granulation
  202. Sweet Berberine
  203. Quantifying effects of moisture content on flow properties of microcrystalline cellulose using a ring shear tester
  204. A critical Examination of the Phenomenon of Bonding Area - Bonding Strength Interplay in Powder Tableting
  205. From molecular salt to pseudo CAB cocrystal: Expanding solid-state landscape of carboxylic acids based on charge-assisted COOH⋯COO− hydrogen bonds
  206. The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance
  207. Dependence of tablet brittleness on tensile strength and porosity
  208. Tabletability Modulation Through Surface Engineering
  209. Development of highly stabilized curcumin nanoparticles by flash nanoprecipitation and lyophilization
  210. Dependence of ejection force on tableting speed—A compaction simulation study
  211. A new tablet brittleness index
  212. Near-infrared chemical imaging (NIR-CI) as a process monitoring solution for a production line of roll compaction and tableting
  213. Validation and applications of an expedited tablet friability method
  214. Correlation Among Crystal Structure, Mechanical Behavior, and Tabletability in the Co-Crystals of Vanillin Isomers
  215. Designing Micellar Nanocarriers with Improved Drug Loading and Stability Based on Solubility Parameter
  216. Significant Expansion of the Solid State Landscape of Salicylic Acid Based on Charge-Assisted Hydrogen Bonding Interactions
  217. Solvent and additive interactions as determinants in the nucleation pathway: general discussion
  218. Nucleation in complex multi-component and multi-phase systems: general discussion
  219. Effect of Heating Rate and Kinetic Model Selection on Activation Energy of Nonisothermal Crystallization of Amorphous Felodipine
  220. Kinetic Entrapment of a Hidden Curcumin Cocrystal with Phloroglucinol
  221. Effect of Crystal Habit on Intrinsic Dissolution Behavior of Celecoxib Due to Differential Wettability
  222. Assessment of the relative performance of a confined impinging jets mixer and a multi-inlet vortex mixer for curcumin nanoparticle production
  223. Design and Preparation of a 4:1 Lamivudine–Oxalic Acid CAB Cocrystal for Improving the Lamivudine Purification Process
  224. Origin of Deteriorated Crystal Plasticity and Compaction Properties of a 1:1 Cocrystal between Piroxicam and Saccharin
  225. A Formulation Strategy for Solving the Overgranulation Problem in High Shear Wet Granulation
  226. Enabling Tablet Product Development of 5-Fluorocytosine Through Integrated Crystal and Particle Engineering
  227. Evolution of Structure and Properties of Granules Containing Microcrystalline Cellulose and Polyvinylpyrrolidone During High-Shear Wet Granulation
  228. Improving manufacturability of an ibuprofen powder blend by surface coating with silica nanoparticles
  229. Enabling direct compression of formulated Danshen powder by surface engineering
  230. Impact of Crystal Habit on Biopharmaceutical Performance of Celecoxib
  231. Design, Synthesis, and Characterization of New 5-Fluorocytosine Salts
  232. A Pitfall in Analyzing Powder Compatibility Data Using Nonlinear Regression
  233. Protonation of Cytosine: Cytosinium vs Hemicytosinium Duplexes
  234. Synthon preference in O-protonated amide crystals – dominance of short strong hydrogen bonds
  235. Improved solid-state stability of salts by cocrystallization between conjugate acid–base pairs
  236. Cocrystallization for successful drug delivery
  237. Preparation and Characterization of Surface-Engineered Coarse Microcrystalline Cellulose Through Dry Coating with Silica Nanoparticles
  238. Correction for Polymorphs, Salts and Cocrystals: What’s in a Name?
  239. Probing Interfaces between Pharmaceutical Crystals and Polymers by Neutron Reflectometry
  240. Polymorphs, Salts, and Cocrystals: What’s in a Name?
  241. Do not confuse hydrogen chloride with hydrochloric acid!
  242. Simultaneously Improving the Mechanical Properties, Dissolution Performance, and Hygroscopicity of Ibuprofen and Flurbiprofen by Cocrystallization with Nicotinamide
  243. Ionized form of acetaminophen with improved compaction properties
  244. Design and synthesis of solid state structures with conjugate acid–base pair interactions
  245. Direct correlation among crystal structure, mechanical behaviour and tabletability in a trimorphic molecular compound
  246. Origin of Two Modes of Non-isothermal Crystallization of Glasses Produced by Milling
  247. Profoundly improving flow properties of a cohesive cellulose powder by surface coating with nano‐silica through comilling
  248. Reproducibility of flow properties of microcrystalline cellulose — Avicel PH102
  249. Initial moisture content in raw material can profoundly influence high shear wet granulation process
  250. Overcoming Poor Tabletability of Pharmaceutical Crystals by Surface Modification
  251. Massing in high shear wet granulation can simultaneously improve powder flow and deteriorate powder compaction: A double-edged sword
  252. Origin of profound changes in powder properties during wetting and nucleation stages of high-shear wet granulation of microcrystalline cellulose
  253. Understanding Size Enlargement and Hardening of Granules on Tabletability of Unlubricated Granules Prepared by Dry Granulation
  254. Decoding Powder Tabletability: Roles of Particle Adhesion and Plasticity
  255. The Manufacture of Low-Dose Oral Solid Dosage Form to Support Early Clinical Studies Using an Automated Micro-Filing System
  256. Transforming Powder Mechanical Properties by Core/Shell Structure: Compressible Sand
  257. Roles of Granule Size in Over-Granulation During High Shear Wet Granulation
  258. Setting the bar for powder flow properties in successful high speed tableting
  259. Understanding the relationship between crystal structure, plasticity and compaction behaviour of theophylline, methyl gallate, and their 1 : 1 co-crystal
  260. Characterization of thermal behavior of deep eutectic solvents and their potential as drug solubilization vehicles
  261. Improving Powder Flow Properties of Citric Acid by Crystal Hydration
  262. Materials Science Tetrahedron—A Useful Tool for Pharmaceutical Research and Development
  263. Development of a high drug load tablet formulation based on assessment of powder manufacturability: Moving towards quality by design
  264. Quantifying Effects of Particulate Properties on Powder Flow Properties Using a Ring Shear Tester
  265. On the Identification of Slip Planes in Organic Crystals Based on Attachment Energy Calculation
  266. Improving Mechanical Properties of Caffeine and Methyl Gallate Crystals by Cocrystallization
  267. Mechanism of moisture induced variations in true density and compaction properties of microcrystalline cellulose
  268. On the mechanism of reduced tabletability of granules prepared by roller compaction
  269. Influence of crystal structure on the tableting properties of n‐alkyl 4‐hydroxybenzoate esters (parabens)
  270. Thermal Expansion of Organic Crystals and Precision of Calculated Crystal Density: A Survey of Cambridge Crystal Database
  271. Insensitivity of Compaction Properties of Brittle Granules to Size Enlargement by Roller Compaction
  272. A material-sparing method for simultaneous determination of true density and powder compaction properties—Aspartame as an example
  273. Solid-state properties and crystallization behavior of PHA-739521 polymorphs
  274. Reduced tabletability of roller compacted granules as a result of granule size enlargement
  275. True Density of Microcrystalline Cellulose
  276. A Study of Sulfamerazine Single Crystals Using Atomic Force Microscopy, Transmission Light Microscopy, and Raman Spectroscopy
  277. Quantifying Errors in Tableting Data Analysis Using the Ryshkewitch Equation Due to Inaccurate True Density
  278. Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction
  279. A Novel Method for Deriving True Density of Pharmaceutical Solids Including Hydrates and Water-Containing Powders
  280. Improved Tableting Properties of p-Hydroxybenzoic Acid by Water of Crystallization: A Molecular Insight
  281. Theophylline monohydrate
  282. Influence of Crystal Shape on the Tableting Performance of L‐Lysine Monohydrochloride Dihydrate
  283. Influence of crystal shape on the tableting performance of L‐lysine monohydrochloride dihydrate
  284. Influence of crystal shape on the tableting performance of L-lysine monohydrochloride dihydrate
  285. Effects of initial particle size on the tableting properties of l-lysine monohydrochloride dihydrate powder
  286. Influence of Elastic Deformation of Particles on Heckel Analysis